A guide to Decentralized Biotech

“Decentralized Biotech” is an emerging trend in the life sciences industry that seeks to democratize information and collaboration to accelerate scientific innovation. This approach leverages technologies such as blockchain and decentralized autonomous organizations (DAOs) to enable global, collaborative networks of researchers working on projects with shared goals. Key examples include Petri’s Frequency program, Phage Directory, and Molecule, a company building an ecosystem for early-stage drug development using IP-NFTs and biotech DAOs. While there are valid reasons to support centralized systems, the decentralized approach could potentially offer benefits such as faster research progress and more efficient knowledge sharing around the world.